Skip to content
10-K

Annual Report

IMMUCELL CORP /DE/ ICCC

0001437749-26-010339

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 9.03M sh
Shares Diluted FY 2025 · Dec 31, 2024 8.17M sh
Capex FY 2025 · Dec 31, 2025 $1.25M
Capex FY 2025 · Dec 31, 2024 $465.73K
Operating Cash Flow FY 2025 · Dec 31, 2025 $2.48M
Operating Cash Flow FY 2025 · Dec 31, 2024 $357.9K
Long Term Debt FY 2025 · Dec 31, 2025 $7.49M
Long Term Debt FY 2025 · Dec 31, 2024 $9.04M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.81M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.76M
Stockholders Equity FY 2025 · Dec 31, 2025 $27.06M
Stockholders Equity FY 2025 · Dec 31, 2024 $27.52M
Stockholders Equity FY 2025 · Dec 31, 2023 $24.99M
Current Liabilities FY 2025 · Dec 31, 2025 $3.98M
Current Liabilities FY 2025 · Dec 31, 2024 $4.41M
Total Liabilities FY 2025 · Dec 31, 2025 $15.48M
Total Liabilities FY 2025 · Dec 31, 2024 $17.58M
Current Assets FY 2025 · Dec 31, 2025 $16.94M
Current Assets FY 2025 · Dec 31, 2024 $15.04M
Total Assets FY 2025 · Dec 31, 2025 $42.53M
Total Assets FY 2025 · Dec 31, 2024 $45.1M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.12
Eps Diluted FY 2025 · Dec 31, 2024 −$0.26
Eps Basic FY 2025 · Dec 31, 2025 −$0.12
Eps Basic FY 2025 · Dec 31, 2024 −$0.26
Sga Expense FY 2025 · Dec 31, 2025 $3.2M
Sga Expense FY 2025 · Dec 31, 2024 $2.22M
Rd Expense FY 2025 · Dec 31, 2025 $3.04M
Rd Expense FY 2025 · Dec 31, 2024 $3.9M
Net Income FY 2025 · Dec 31, 2025 −$1.04M
Net Income FY 2025 · Dec 31, 2024 −$2.16M
Operating Income FY 2025 · Dec 31, 2025 $1.65M
Operating Income FY 2025 · Dec 31, 2024 −$1.64M
Gross Profit FY 2025 · Dec 31, 2025 $11.45M
Gross Profit FY 2025 · Dec 31, 2024 $7.94M
Cost Of Revenue FY 2025 · Dec 31, 2025 $16.2M
Cost Of Revenue FY 2025 · Dec 31, 2024 $18.55M
Revenue FY 2025 · Dec 31, 2025 $27.64M
Revenue FY 2025 · Dec 31, 2024 $26.49M
Stock Issued FY 2025 · Apr 30, 2021 4.55M sh